Related Experiment Video
Updated: Apr 16, 2026
07:58
Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
Published on: February 25, 2014
30.1K
Progranulin knockout accelerates intervertebral disc degeneration in aging mice
Yun-peng Zhao1, Qing-yun Tian2, Ben Liu2
11] Department of Orthopaedic Surgery, New York University Medical Center, New York, NY. 10003 [2] Department of Spinal Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.
Scientific Reports
|March 18, 2015
Summary
Progranulin (PGRN) is crucial for maintaining intervertebral disc (IVD) health. Loss of PGRN accelerates disc degeneration and bone changes in aging mice, highlighting its potential as a therapeutic target.
Area of Science:
- Biochemistry
- Orthopedics
- Cell Biology
Background:
- Intervertebral disc (IVD) degeneration is a prevalent condition with poorly understood pathogenesis.
- Progranulin (PGRN), a known chondroprotective growth factor, has not been extensively studied in the context of IVD degeneration.
Purpose of the Study:
- To investigate the role of progranulin (PGRN) in the pathogenesis of intervertebral disc (IVD) degeneration.
- To determine if PGRN levels correlate with IVD aging and degeneration.
Main Methods:
- Detection of PGRN in human and murine IVD tissues.
- Analysis of PGRN expression levels during murine IVD aging.
- Phenotypic analysis of PGRN knockout mice, including IVD matrix integrity, bone formation, and resorption.
- Investigation of signaling pathways (NF-κB, β-catenin) in PGRN-deficient mice.
Main Results:
- PGRN is present in both human and murine IVD tissues.
- PGRN levels increase in murine IVD with age.
- PGRN deficiency leads to early-onset IVD degeneration, altered gene expression, and accelerated matrix degeneration in aging mice.
- PGRN knockout mice show abnormal vertebral bone formation and increased bone resorption.
- Enhanced NF-κB and β-catenin signaling pathways are implicated in accelerated degeneration in PGRN-null mice.
Conclusions:
- PGRN plays a significant role in maintaining intervertebral disc (IVD) homeostasis.
- PGRN deficiency exacerbates age-related IVD degeneration and associated vertebral bone changes.
- PGRN represents a potential molecular target for therapeutic strategies aimed at preventing or treating disc degenerative diseases.
